–
Taysha Gene Therapies, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−173
FY22:
−162
FY23:
−72.4
FY24:
−91.5
FY25:
−110
(positive)
Change from FY21 to FY25
millions USD
FY21:
−173
FY22:
–
FY23:
–
FY24:
–
FY25:
−107
(positive)
Change from FY21 to FY25
millions USD
FY21:
−175
FY22:
–
FY23:
–
FY24:
–
FY25:
−109
(positive)
Change from FY21 to FY25
millions USD
FY21:
−175
FY22:
−166
FY23:
−112
FY24:
−89.3
FY25:
−109
All amounts in millions USD